AU2002354841A1 - Engineering oncolytic viruses - Google Patents

Engineering oncolytic viruses

Info

Publication number
AU2002354841A1
AU2002354841A1 AU2002354841A AU2002354841A AU2002354841A1 AU 2002354841 A1 AU2002354841 A1 AU 2002354841A1 AU 2002354841 A AU2002354841 A AU 2002354841A AU 2002354841 A AU2002354841 A AU 2002354841A AU 2002354841 A1 AU2002354841 A1 AU 2002354841A1
Authority
AU
Australia
Prior art keywords
oncolytic viruses
engineering
engineering oncolytic
viruses
oncolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354841A
Inventor
Faris Farassati
Patrick W.K. Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002354841A1 publication Critical patent/AU2002354841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002354841A 2001-07-17 2002-07-17 Engineering oncolytic viruses Abandoned AU2002354841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2352439 CA2352439A1 (en) 2001-07-17 2001-07-17 Engineering oncolytic viruses
CA2,352,439 2001-07-17
PCT/CA2002/001108 WO2003008586A2 (en) 2001-07-17 2002-07-17 Engineering oncolytic viruses

Publications (1)

Publication Number Publication Date
AU2002354841A1 true AU2002354841A1 (en) 2003-03-03

Family

ID=4169411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002354841A Abandoned AU2002354841A1 (en) 2001-07-17 2002-07-17 Engineering oncolytic viruses

Country Status (3)

Country Link
AU (1) AU2002354841A1 (en)
CA (1) CA2352439A1 (en)
WO (1) WO2003008586A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
WO2007087580A2 (en) * 2006-01-24 2007-08-02 The University Of Chicago Y134.5 deficient hsv comprising a coding region of a member of the mapk pathway for the treatment of a cell proliferation disorder
CA2734740A1 (en) 2008-08-21 2010-02-25 Ottawa Hospital Research Institute Engineered synergistic oncolytic viral symbiosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118942A (en) * 1995-07-27 2002-09-12 American Cyanamid Co Avirulent herpetic viruses useful as tumoricidal agents and vaccines
JPH1087503A (en) * 1996-09-06 1998-04-07 Nippon Chem Res Kk Apoptosis agent against neuroma cells
HUP0302278A3 (en) * 1999-04-15 2011-01-28 Pro Virus Treatment of neoplasms with viruses

Also Published As

Publication number Publication date
WO2003008586A2 (en) 2003-01-30
CA2352439A1 (en) 2003-01-17
WO2003008586A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
HUP0400882A3 (en) Oncolytic virus therapy
AU2001231752A1 (en) Cook-top
AU2002317568A1 (en) Technical field
AUPQ912000A0 (en) Improved virus like particles
AU2002363912A1 (en) Modified class loaders
AU2002214081A1 (en) Listeria inocua, genome and applications
AU2002343312A1 (en) Two fixed-beams tx-diversity
AU2002219481A1 (en) Combination square
AU2002220416A1 (en) Oncolytic virus
AUPR160400A0 (en) Plant virus promoter
AU2002354841A1 (en) Engineering oncolytic viruses
GB0001475D0 (en) Virus strains
AU2002224845A1 (en) Viral expression system
AU2003213818A1 (en) Altering viral tropism
AU2002245337A1 (en) Epoxyvibsanin b
AU2001234644A1 (en) Methods for inactivating viruses
GB0100288D0 (en) Virus strains
GB0100430D0 (en) Virus strains
GB0106066D0 (en) Psuedotyped viruses
AU2002251991A1 (en) Modified square
AU2002218962A1 (en) Stroller
AUPR339601A0 (en) Barrow
AU2002241809A1 (en) Trusted intermediary
AU2002237636A1 (en) Message handling
AUPR477701A0 (en) Operational turning

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase